Norwegian health think tank recommends government ban Johnson & Johnson and AstraZeneca

The National Archives reported on May 10 that Norway’s Institute of Public Health (NIPH) has recommended that the country’s government avoid the use of vaccines for the Chinese communist virus from Johnson & Johnson (J&J) and AstraZeneca, citing severe side effects that caused by blood clotting that has claimed the lives of five Norwegians.

Lars Vorland, chairman of the investigation committee at the Norwegian Institute of Public Health, said at a press conference on Monday that “there is a great deal of uncertainty about the serious but rare side effects from the use of the Johnson & Johnson vaccine. After AstraZeneca vaccination, Norway registered a higher incidence of serious side effects and death after the first dose compared to other countries, and we do not yet know the cause.”

Volan explained, “The data on the incidence of serious side effects from the Johnson & Johnson vaccine are from the U.S., where there are 0.7 per 100,000 vaccinated women under 50 years of age, and at this rate, women in Norway between the ages of 18 and 50 are at greater risk of getting the Johnson & Johnson vaccine than waiting to get the mRNA vaccine. “

In the United States, there have been multiple side effects following the use of Johnson & Johnson’s vaccine, including the paralysis of a mother in Tennessee.

The Norwegian government has not issued an official decision on whether it will stop using either vaccine.